Evidence map›Paper›PMID 22419223›Full record

ArticleGlia2012

The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage.

Yao Yao, Stella E Tsirka

Open access · greenAbstract read
In one paragraph

Article in Glia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. A dispensable role of mural cell-derived laminin-Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Lipoxin ABrain sciences · 2022
    Article
  14. Review
  15. MCP-1: Function, regulation, and involvement in disease.International immunopharmacology · 2021
    Review
  16. Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yao YaoDepartment of Pharmacological Sciences, Program in Molecular and Cellular Pharmacology, Stony Brook University, Stony Brook, NY, USA.
Stella E Tsirka
Stony Brook University · US

Funding

Training Program in Pharmacological SciencesT32GM007518 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI GARCIA-DIAZ, MIGUEL · 1985 to 2021
$5.4M
Microglial effector pathways in the CNSR01NS042168 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TSIRKA, STYLIANI-ANNA (STELLA) E · 2003 to 2011
$3.1M
NIGMS NIH HHS T32 GM007518NINDS NIH HHS R01 NS042168PHS HHS R0142168
6 · The paper itself

Abstract

Intracerebral hemorrhage (ICH) has been associated with inflammation and apoptosis. The CCL2-CCR2 chemotactic system is one of the major signaling pathways that induce inflammation and apoptosis. However, its role on ICH has not been investigated. We subjected wild-type, CCL2(-/-) , and CCR2(-/-) mice to collagenase-induced ICH, and assessed histological and behavioral outcomes. Lack of CCL2 or CCR2 decreased the hematoma volume early after collagenase-induced ICH but delayed its recovery. The hematoma size was accompanied by brain edema, neuronal death, and neurological scores. Although microglia activation/migration was attenuated in CCL2(-/-) or CCR2(-/-) mice 1 day after injury, more microglia were present at later time points, suggesting that alternative signaling pathways had been activated to recruit them. On the contrary, leukocyte and neutrophil infiltration were decreased in these mice, suggesting a tighter/recovered blood-brain barrier. In addition, we also found that FL- and K104Stop-CCL2 were able to restore the changes found in CCL2(-/-) mice, but K104A-CCL2 failed to do so. These results suggest that plasmin-mediated truncation of CCL2 may be an indispensable step to fully activate the chemokine in vivo. The data also indicate that CCL2-CCR2 signaling pathway may be a molecular target for the treatment of ICH.

Indexed as

Analysis of VarianceAnimalsAntigens, LyBrain EdemaCalcium-Binding ProteinsCerebral HemorrhageChemokine CCL2Chemotaxis, LeukocyteCollagenasesDisease Models, AnimalDisease ProgressionFluoresceinsFunctional LateralityGene Expression RegulationLeukocyte Common AntigensMacrophagesAif1 protein, mouseAntigens, LyCalcium-Binding ProteinsCcl2 protein, mouseCcr2 protein, mouseChemokine CCL2CollagenasesFluoresceinsfluoro jadeLeukocyte Common AntigensLy6G antigen, mouseMicrofilament ProteinsNitric Oxide Synthase Type IIOrganic ChemicalsReceptors, CCR2

Identifiers

PMID22419223
PMCPMC3325358
OpenAlexW2024880119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.